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Staphylococcus aureus is a remarkably adaptable organism capable of multiple modes of growth in the human
host, as a part of the normal flora, as a pathogen, or as a biofilm. Many of the regulatory pathways governing
these modes of growth are centered on the activities of two regulatory molecules, the DNA binding protein SarA
and the regulatory RNAIII effector molecule of the agr system. Here, we describe the modulation of these
regulators and their downstream target genes by SarZ, a member of the SarA/MarR family of transcriptional
regulators. Transcriptional and phenotypic analyses of a sarZ mutant demonstrated that the decreased
transcription of mgrA and the agr RNAIII molecule was accompanied by increased transcription of spa (protein
A) and downregulation of hla (alpha-hemolysin) and sspA (V8 protease) transcripts when compared to its
isogenic parent. The decrease in protease activity was also associated with an increase in SarA expression.
Consistent with an increase in SarA levels, the sarZ mutant displayed an enhanced ability to form biofilms.
Together, our results indicate that SarZ may be an important regulator governing the dissemination phase of
S. aureus infections, as it promotes toxin expression while repressing factors required for biofilm formation.
Staphylococcus aureus is a gram-positive organism that col-
onizes the anterior nares of approximately 30% of the normal
population. Infections can occur when there is a breach in the
immune defenses of the host. Diseases caused by S. aureus
vary, depending on the site of colonization, and can range from
superficial skin lesions to invasive syndromes, such as pneumo-
nia, endocarditis, osteomyelitis, and septicemia (3, 8). Adding
to the seriousness of these infections is the propensity of S.
aureus to form biofilms, which often leads to the establishment
of chronic infections that are difficult to treat (12). The switch-
ing from the commensal, to the invasive, to the biofilm modes
of growth is due in part to the complex repertoire of regulatory
molecules that S. aureus uses to sense and respond to its en-
vironment.
The complex nature of the regulatory pathways governing
virulence and biofilm formation in S. aureus arises from the
fact that multiple regulators can activate or repress a single
target gene. Detailed examination of the regulation of several
virulence genes, such as spa (protein A), hla (alpha-hemoly-
sin), and sspA (V8 protease), has revealed the following trends
(3, 26–28, 36). First, gene expression occurs in a temporal
fashion such that cell wall proteins and surface adhesins are
expressed during the early, colonizing stages of infection,
whereas toxins and secreted proteins are expressed later, dur-
ing the tissue-damaging phase of disease. Second, the agr quo-
rum-sensing system and the SarA family of DNA binding pro-
teins form the cornerstone of virulence gene regulation in
staphylococci. Together, these regulators control the expres-
sion of over a hundred genes that are involved in a myriad of
cellular functions (11).
The agr system is comprised of two divergent transcripts
(RNAII and RNAIII) that are activated in response to cell
density. RNAII encodes a quorum-sensing two-component
regulatory system that is activated by the autoinducing peptide.
The RNAIII transcript, presumably activated by its cognate
two-component regulatory system, is the agr effector molecule
that activates the transcription of toxin genes such as hla and
sspA and represses surface protein genes, such as spa, through
its direct action or via intermediary regulators such as SarS,
SarT, Rot, and SaeRS (14, 23, 25, 32).
The sarA gene encodes a DNA binding protein belonging to
the SarA protein family of winged-helix transcriptional regu-
lators (7). The SarA protein binds and activates the promoters
of a number of genes, including agr, and represses other genes,
such as sspA and spa (5, 9). Like agr, SarA also controls gene
expression indirectly through its effect on other regulatory mol-
ecules. For example, the positive effect of SarA on hla is be-
lieved to be mediated in part by the repressor SarT (27).
Many members of the SarA family have been characterized
and the majority of them have roles in controlling the expression
of genes involved in virulence (7). One SarA homologue, SarZ,
was previously reported to restore hemolysis in a mutant lacking
that capability (18). We have now expanded that role to the
general promotion of virulence through the activation of agr and
repression of SarA. Additionally, we demonstrate a role for SarZ
in the repression of biofilm formation, presumably through its
effect on sarA. Together, these results suggest that SarZ plays an
important role in the maintenance of active S. aureus infections.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and reagents. The bacterial strains used
in this study are listed in Table 1. S. aureus strains were routinely cultured on
tryptic soy agar or broth (TSB) or 03GL broth (24). Escherichia coli strains were
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grown on Luria-Bertani agar or broth. Antibiotics for plasmid selection and
maintenance were used at the following concentrations: S. aureus, 2.5 g/ml
erythromycin and 10 g/ml chloramphenicol; E. coli, 100 g/ml ampicillin. All
strains were grown in 18-mm borosilicate glass tubes at 37°C in an Excella E24
incubator (New Brunswick Scientific, Edison, NJ) with shaking at 250 rpm unless
indicated otherwise. Bacterial growth was monitored by measuring the optical
density at 650 nm (OD650) on a Spectronic 20D spectrophotometer (Spec-
tronic Analytical Instruments, Garforth, England). Early exponential, late expo-
nential, and postexponential growth phases corresponded to OD readings of 0.7,
1.1, and 1.7, respectively, at 650 nm.
All chemicals and reagents were obtained from either Fisher or Sigma unless
noted otherwise. Enzymes and reagents used for genetic manipulations were
obtained from New England Biolabs.
Oligonucleotides and strain construction. A list of the oligonucleotides used
in this study is available from the authors upon request. DNA isolation, electro-
phoresis, PCRs, transformation of E. coli and S. aureus, and other genetic
manipulations were carried out according to standard laboratory protocols. Plas-
mid DNA from E. coli was first introduced into the heavily mutagenized, DNA
restriction system-deficient S. aureus strain RN4220 prior to transfer into other
S. aureus strains.
An unmarked, in-frame deletion of sarZ was constructed by employing a PCR
splicing by overlap extension approach. Briefly, 1-kb regions up and downstream
of the sarZ coding region were amplified using primers with complementary 9-bp
overhangs. The resulting amplicons were used as the template to create a com-
posite DNA fragment missing sarZ. This fragment was cloned into pMAD, a
shuttle vector with a temperature-sensitive origin of replication in S. aureus (1).
Through a series of temperature shifts from 30°C to 44°C, the sarZ deletion
construct was obtained via a double-crossover event in the chromosome, replac-
ing the native sarZ chromosomal region with the one containing the in-frame
markerless deletion. A similar approach, wherein the native sarZ gene was
crossed back into the chromosome of the sarZ mutant, was used to create the
sarZ-complemented strain. The sarA sarZ double mutant was constructed by
introducing the pMAD derivative pALC5448 into the sarZ mutant, allowing for
the replacement of the native sarA gene with the mutant allele. Correct clones
were identified by PCR and confirmed by sequencing.
The SspA- and MgrA-overproducing strains were created by amplifying the
respective open reading frames and cloning them downstream of the xylose-
inducible promoter of the S. aureus expression vector pEPSA5 (13). The respec-
tive promoter sequences of these genes were also amplified and cloned upstream
of the gfpuvr gene in the E. coli-S. aureus shuttle vector pALC1484 to create
transcriptional fusions (17). The RNAIII-overproducing strain was constructed
by introducing pRN6735 into the sarZ mutant.
Northern hybridizations. RNA was isolated from approximately 1.6  1011
CFU from early exponential phase (OD650, 0.7), late exponential phase (OD650,
1.1), or postexponential phase (OD650, 1.7) cells grown in TSB. Cells were lysed
in Trizol according to the manufacturer’s protocol (Invitrogen, Irving, CA) using
0.1-mm silica-zirconia beads and a reciprocating shaker (BIO 101, Vista, CA).
Ten micrograms of RNA was separated on a 1.5% agarose–0.66 M formaldehyde
gel in 20 mM morpholinepropanesulfonic acid, 10 mM sodium acetate, 2 mM
EDTA (pH 7) at 80 V for 3 h, transferred to a nylon membrane (Amersham
HyBond XL; GE Healthcare, Piscataway, NJ) in 20 SSC (3 M NaCl, 0.3 M
sodium citrate, pH 7), and fixed by baking the membranes at 80°C for 2 h.
Membranes were prehybridized in 5 SSC, 0.5% sodium dodecyl sulfate, and 5
Denhardt’s solution (0.1% bovine serum albumin, 0.1% Ficoll 400, 0.1% poly-
vinylpyrrolidone) for 4 h at 65°C. Purified DNA fragments were labeled with the
random primed DNA labeling kit (Hoffmann-La Roche Inc., Nutley, NJ) and
allowed to hybridize to the membranes overnight at 65°C. Posthybridization, the
membranes were washed extensively and the bands were visualized by autora-
diography. The relative intensities of the resulting bands were determined by
using ImageJ (30). Data shown are representative of at least three hybridizations.
Green fluorescent protein (GFP)-promoter fusion analysis. Shuttle plasmids
containing the promoter regions of various genes driving the expression of
GFPuvr (Table 1) were electroporated into the wild-type, sarZ mutant, and
complemented strains by electroporation as previously described (31). Overnight
cultures of the resulting strains were diluted 1:100 into fresh TSB and incubated
at 37°C with shaking. Aliquots of the cultures were removed at specified time
points, and their growth and fluorescence were monitored using an FL600 mi-
croplate fluorescence reader (BioTek Instruments, Winooski, VT). Experiments
were repeated three times using four independently isolated clones read in
triplicate. Error bars represent standard deviations of the means. Statistical
significance was calculated using Student’s t test.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western
transfer. Cell lysates were prepared by harvesting approximately 1.6  1011 CFU
from exponential-phase cells, resuspending the pellets in TEG buffer (25 mM
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Description Reference
S. aureus strains
RN4220 Heavily mutagenized strain that accepts foreign DNA, agr-deficient 24
RN6390 Laboratory strain related to strain 8325-4 29
SH1000 8325-4 with rsbU restored 15
ALC6374 RN6390 sarZ This work
ALC6366 SH1000 sarZ This work
ALC6367 RN6390 sarZ/sarZ complement This work
ALC6368 RN6390 sarZ with pEPSA5 This work
ALC6369 RN6390 sarZ with pEPSA5::sspA This work
ALC6370 RN6390 sarZ with pEPSA5::mgrA This work
ALC6410 RN6390 sarZ sarA This work
ALC6409 RN6390 sarZ with pRN6735 (blaZ promoter driving RNAIII) This work
E. coli strain TOP10 General cloning strain
Plasmids
pMAD E. coli-S. aureus shuttle vector containing a thermosensitve origin of replication, bgaB,
Emr Apr
1
pEPSA5 E. coli-S. aureus shuttle vector containing a xylose-inducible promoter, Apr Cmr 13
pALC1484 E. coli-S. aureus shuttle vector derived from pSK236 containing the gfpuvr gene, Ap
r Cmr 17
pALC1540 sarA triple promoter driving the expression of gfpuvr in pALC1484 21
pALC1435 sarA P1 promoter driving the expression of gfpuvr in pALC1484 21
pALC1743 agr P3 promoter driving the expression of gfpuvr in pALC1484 17
pALC1741 spa promoter driving the expression of gfpuvr in pALC1484 19
pALC1740 hla promoter driving the expression of gfpuvr in pALC1484 19
pALC2831 sspA promoter driving the expression of gfpuvr in pALC1484 This work
pALC2566 mgrA promoter driving the expression of gfpuvr in pALC1484 This work
pALC5448 pMAD containing a sarA deletion fragment generated by PCR 34
pRN6735 blaZ promoter driving the expression of promoterless RNAIII, Cmr 35
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Tris-Cl, pH 8, 25 mM EGTA), and lysing the cells using 0.1-mm silica-zirconia
beads and a reciprocating shaker. The proteins were separated from cellular
debris by centrifugation at 12,000  g for 5 min at 4°C and quantitated using the
bicinchoninic acid protein assay kit (Pierce, Rockford, IL). An equivalent
amount of protein (75 g) was separated by electrophoresis on 12.5% acrylamide
gels, transferred onto polyvinylidene difluoride membranes (Millipore, Billerica,
MA), and analyzed by Western blotting according to standard protocols. The
primary antibody used was murine anti-SarA monoclonal antibody (1:1,000 di-
lution) (21), and the secondary antibody was donkey anti-mouse immunoglobulin
G conjugated to horseradish peroxidase (1:10,000 dilution; Jackson Immuno-
Research Laboratories, West Grove, PA). Binding of the antibodies to the
membrane was detected using the ECL Western blotting detection system ac-
cording to the manufacturer’s instructions (GE Healthcare). Densitometry was
performed using ImageJ (30).
Protease detection assays. Protease production was tested by spotting 2 l of
1010 cells/ml onto agar plates containing 5% skimmed milk followed by incuba-
tion at 37°C for 24 h. Alternatively, proteins from 30 l of culture supernatant
from overnight bacterial cultures normalized to 1010 cells/ml were separated
electrophoretically on 12.5% acrylamide gels containing 1 mg/ml gelatin. After
electrophoresis, the gel was washed with gentle shaking in phosphate-buffered
saline containing 2.5% Triton X-100 for 1 hour at room temperature and incu-
bated overnight in protease detection buffer (50 mM Tris-HCl, pH 7.5, 200 mM
NaCl, 5 mM CaCl2, 1 mM cysteine, 0.2% Triton X-100) at 37°C with shaking.
The gel was then stained in Coomassie brilliant blue R-250 and destained
according to standard procedures to visualize protease activity as zones of clear-
ing on a blue background.
Biofilm formation and detachment assays. Biofilms were formed in 96-well
polystyrene plates according to the method of Caiazza and O’Toole (4). Cells
were inoculated at a concentration of 107 cells/ml into 100 l of 66% TSB
containing 0.2% glucose or a mixture of 2% xylose and 2% glucose and incubated
for 16 h at 37°C. The culture supernatant and nonadherent bacteria were re-
moved by decanting and then washing the wells three times with water. Biofilms
were stained with 0.1% crystal violet for 15 min and washed again three times
with water. The crystal violet was released from the adherent cells with absolute
ethanol and quantified by reading its absorbance at 562 nm.
For detachment studies, preformed biofilms were treated with 100 l 20 mM
Tris-Cl (pH 7.5), 100 g/ml protease K, or 0.14 U/ml DNase I (Roche) at 37°C
for 2 h. Washing and staining of the biofilms were carried out as described above.
Data shown are representative of three independent experiments with at least six
replicates each. Error bars represent the standard deviations of the means.
Statistical significance was calculated using Student’s t test.
RESULTS
Transcriptional profile of the sarZ gene. SarZ was originally
identified based on its homology with members of the SarA
protein family of S. aureus. The sarZ locus, SA2174, is located
near genes involved in the nitrate/nitrite utilization pathways in
S. aureus. However, despite this proximity, sarZ does not ap-
pear to be in an operon with any of them. Directly downstream
of sarZ is an uncharacterized gene that is predicted to encode
a chaperone based on its sequence similarity to genes of the
heat shock protein family bearing an alpha-crystallin domain
(10).
We initially chose to study sarZ in the RN6390 background
because this strain has been well-characterized and is accom-
panied by an assortment of regulatory mutants which have
been evaluated previously (7). However, recognizing that
RN6390 has a defective rsbU, which is required to activate the
alternative sigma factor B, we conducted relevant phenotypic
studies in strain SH1000, which has a restored rsbU (16) (see
below).
The transcriptional profile of the sarZ gene in the wild-type
strain RN6390 during various points of the S. aureus cell cycle
was assessed by Northern blotting (Fig. 1B). The sarZ tran-
script appeared as two hybridizing bands, with a predominant
species at 450 bp, the expected size of the monocistronic sarZ
transcript, and a larger species at 1.5 kb, which likely corre-
sponds to the cotranscription of sarZ with the putative chap-
erone SA2175 (Fig. 1A). As the growth cycle progressed, the
level of sarZ transcript reached a maximal level during the late
exponential phase (OD650, 1.1). The level of the smaller sarZ
transcript decreased during the postexponential phase (OD650,
1.7), while the larger 1.5-kb transcript was not detectable. As
expected, both transcripts were undetectable in the sarZ mu-
tant, and the temporal pattern of sarZ transcription was re-
stored upon complementation of the sarZ mutation.
Effect of a sarZ mutation on transcription of regulatory
genes. Based on its similarity to SarA, we hypothesized that
SarZ may be involved in regulation of the S. aureus virulence
cascade. To test this hypothesis, the transcriptional profile of a
sarZ deletion mutant was compared to that of the parental
strain RN6390 and a complemented sarZ mutant strain. The
levels of SarA in two independently isolated sarZ mutants were
first assessed by immunoblotting. Compared to the parent
strain, the two sarZ mutants had a two- to threefold increase in
SarA protein level, suggesting that SarZ may have had a re-
pressive effect on SarA expression (Fig. 2A). To confirm this,
we analyzed sarA transcription in the sarZ mutant. The sarA
locus is composed of three overlapping transcripts initiating
from three distinct promoters, P1, P2, and P3 (21), that all
encompass the sarA coding region. Northern blotting data re-
vealed that the sarZ mutant demonstrated a moderate increase
in the sarA P1 transcript during late exponential phase (OD650,
1.1) compared with the parental and complemented strains
(Fig. 2B, left panel). The level of the sarA P1 transcript in the
mutant was similar to that of the parent during the postexpo-
nential phase. GFP-promoter fusion analysis, which reflects
FIG. 1. Transcription of sarZ during the exponential and postex-
ponential phases of growth. A. Genomic context of the sarZ gene.
Numbers within the block arrows indicate the lengths of the genes in
base pairs, and numbers above the arrows indicate the length of the
intergenic regions, also in base pairs. B, left panel. Northern blot
analysis of sarZ transcription in RN6390 during the early exponential
(OD650, 0.7), late exponential (OD650, 1.1), and postexponential
(OD650, 1.7) phases of growth. Right panel. Northern blot analysis of
sarZ transcription in the wild-type RN6390, sarZ mutant, and comple-
mented sarZ mutant strains of S. aureus during late exponential and
postexponential growth. Panels below the Northern blots show the 23S
and 16S rRNAs, which served as the internal loading controls.
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the cumulative promoter activity, indicated that the three
strains had equivalent levels of P1 promoter activity during
growth. When the collective strength of the native triple sarA
promoter was investigated, its activity in the sarZ mutant was
moderately, but significantly (P  0.001), increased in compar-
ison with the wild-type and complemented strains (Fig. 2B,
right panel).
As SarA is a key regulator of agr, the level of agr RNAIII
transcription was assessed in the sarZ mutant (Fig. 2C). Both
Northern blotting and GFP-promoter fusion analyses indi-
cated that the RNAIII transcript was strongly downregulated
in the sarZ mutant in comparison with the wild-type and com-
plemented strains.
Given that the levels of SarA were increased in a sarZ-
deficient background and that SarA is an activator of agr, we
reasoned that SarZ may have exerted its effect on agr indepen-
dently of SarA. To evaluate this, we investigated the possibility
that SarZ may have acted on downstream genes via SarR, a
repressor of SarA and activator of agr (22). However, the level
of sarR transcription was unchanged in the sarZ mutant in
comparison to the wild type (data not shown), implying that
SarZ likely activated agr independently of SarR as well as
SarA.
Effect of a sarZ mutation on transcription of virulence genes.
The repression of SarA and activation of agr by SarZ suggested
that SarZ is an important player in the S. aureus virulence
cascade. Therefore, the transcription of three virulence factor
genes, controlled differentially by both SarA and agr, was ex-
FIG. 2. Effect of sarZ on the expression of sarA and agr. A. Western blot analysis of SarA protein expression in the wild-type RN6390 and two
independently isolated sarZ mutant clones of S. aureus. B and C, left panels. Northern blot analysis of sarA (B) and agr RNA III (C) transcription
in the wild-type RN6390, sarZ mutant, and complemented sarZ mutant strains of S. aureus. Right panels. GFP-fusion analysis of the sarA triple
promoter (black), sarA P1 promoter (gray), and agr RNAIII promoter activity in RN6390, sarZ mutant, and complemented strains of S. aureus.
Numbers underneath the panels indicate the relative intensities or sum of the intensities of the bands as determined with Image J. Panels below
the Northern blots show the 23S and 16S rRNAs, which served as the internal loading controls. *, P  0.01, determined with Student’s t test.
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amined in an attempt to delineate the regulatory network
controlled by SarZ. The expression of the protein A gene, spa,
is repressed by both SarA and agr. Northern blot analysis
indicated that spa transcription was increased twofold in the
sarZ mutant in comparison with the wild-type and comple-
mented strains (Fig. 3A, left panel). This upregulation was
confirmed by GFP-promoter fusion analysis. Given that SarA
levels were increased in the sarZ mutant while RNAIII levels
were decreased, these data indicated that SarZ probably re-
presses spa expression by acting through a pathway mediated
by agr. Indeed, provision of RNAIII in trans to the sarZ mutant
halved the transcription of spa. As expected, removing sarA, a
strong repressor of spa, from the sarZ mutant increased spa
transcription by approximately 2.4-fold (Fig. 3A, center panel),
indicating that these two regulators exert their effects upon spa
independently of each other.
The transcription of hla, which encodes alpha-hemolysin,
was moderately reduced in postexponentially growing sarZ
mutant cells in comparison to the wild-type and complemented
strains (0.7 versus 1) (Fig. 3B). The decrease in hla promoter
activity was more evident when analyzing the GFP-promoter
fusion activities during the growth cycle in the mutant versus
the parent and complemented mutant strains. Deleting sarA
from the sarZ mutant decreased hla transcription by fivefold,
while providing RNAIII in trans increased hla transcription
back to wild-type levels. Since sarZ activated agr while repress-
ing sarA, and both of these activate hla, these data implied that
the net effect of SarZ on hla transcription may be due to
competing forces of agr and SarA.
The gene encoding the serine protease, sspA, is differentially
regulated by agr and SarA. SarA represses the protease gene
while agr activates it. As predicted, from the effect of sarZ upon
SarA and agr, the transcription of sspA was markedly reduced
(by approximately 10-fold) upon deletion of the sarZ gene
(Fig. 3C, left panel). However, when sarA was deleted from the
sarZ mutant or when RNAIII was provided in trans, the level
of sspA transcription did not increase as expected (Fig. 3C,
center panel). These data indicate that sarZ may activate sspA
independently of both SarA and agr. Consistent with the tran-
scriptional data, the sarZ mutant did not exhibit any detectable
protease activity on either a skimmed milk agar plate or poly-
acrylamide gel containing gelatin (Fig. 3D).
Involvement of SarZ in biofilm formation. During the
course of this work, it was noted that liquid cultures of the sarZ
mutant settled out of solution more readily than either the
wild-type or complemented strains, a phenotype that is fre-
quently seen in biofilm-producing strains. Accordingly, a bio-
film formation assay in a 96-well polystyrene plate format was
performed; the sarZ mutant was found to have an increased
ability to form biofilms in comparison to the parent and com-
plemented mutant (Fig. 4A).
In S. aureus, the major biofilm exopolysaccharide, poly-N-
acetylglucosamine (PNAG), is encoded by the icaADBC
operon (12). However, Northern blot and GFP-promoter fu-
sion analyses failed to demonstrate an alteration in the tran-
scription of the ica genes in a sarZ mutant (data not shown),
suggesting that the major constituent of biofilms formed by the
sarZ mutant was not PNAG. Treatment of preformed biofilms
with proteinase K promoted detachment of the biofilms,
whereas treatment with DNase I did not. This result suggested
that the biofilm-forming capacity of the sarZ mutant was likely
protein mediated (Fig. 4B).
We also reasoned that the ability of the sarZ mutant to
produce robust biofilms may have been due to the marked
reduction in endogenous protease production. To confirm this
hypothesis, the sspA gene was provided in trans to the mutant.
The resultant strain was able to produce protease (Fig. 5,
middle panel) and more importantly, exhibited reduced bio-
film formation, to the level of the parental strain (Fig. 5, top
and bottom panels).
Effect of SarZ on MgrA expression. Recently, unpublished
data from our lab has demonstrated that another SarA homo-
logue, MgrA, is involved in the repression of biofilm formation
in an ica-independent manner, akin to that of SarZ. Hence, we
sought to determine whether SarZ was involved in the regula-
tion of MgrA. Both Northern and GFP-promoter fusion anal-
yses demonstrated a noticeable decrease in mgrA transcrip-
tional activity in the sarZ mutant compared with the parent,
consistent with the notion that SarZ is an activator of mgrA
(Fig. 6A). Provision of mgrA in trans under the control of an
exogenous promoter was able to curtail biofilm formation of
the sarZ mutant down to the levels of the wild-type strain (Fig.
6B). Although sarZ and mgrA are both positive regulators of
agr and sspA, the effect of SarZ on biofilms likely occurred
independently of agr and sspA, since provision of mgrA to the
sarZ mutant in trans did not complement the transcription of
these two genes, nor did it restore protease production in the
sarZ mutant (Fig. 6C).
Role of SarZ in S. aureus strain SH1000. Our current un-
derstanding of virulence gene regulation in S. aureus is primar-
ily through the study of laboratory strains derived from or
closely related to RN6390 (16, 22, 26, 36). RN6390, however,
has a deletion in rsbU, which encodes a phosphatase required
for the activation of the alternative sigma factor B. As SigB has
been implicated in the control of several virulence genes and
biofilm formation, we sought to determine whether the effects
we observed in the sarZ mutant of RN6390 were applicable to
strain SH1000, a strain similar to RN6390 but with a restored
rsbU (15). As observed with strain RN6390, sarZ was tran-
scribed maximally in SH1000 during the late exponential phase
of growth (Fig. 7A). Analysis of the levels of SarA, agr, and
mgrA in two independently isolated sarZ mutants in SH1000
also mirrored results obtained with strain RN6390. In partic-
ular, the SarA protein level appeared to be repressed by SarZ,
while transcription of agr and mgrA was activated by sarZ (Fig.
7B). In association with these regulatory changes, the sarZ
mutant of SH1000 also demonstrated enhanced biofilm pro-
duction compared with the parent (Fig. 7C). These data sug-
gest that the regulatory profile and the biofilm-positive pheno-
type of the sarZ mutants occurred independently of the
alternative sigma factor B.
DISCUSSION
In this study, we have shown by transcriptional and pheno-
typic analyses that SarZ plays an important role in the S. aureus
virulence cascade (Fig. 8). Inactivation of sarZ in two strains of
S. aureus resulted in elevated production of SarA in compari-
son to the respective parental strains. Using strain RN6390 as
a model and building upon the accumulated regulatory data
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FIG. 3. Effect of sarZ on transcription of spa, hla, and sspA. (Left and center panels) Northern blot analyses of spa (A), hla (B), and sspA
(C) in the RN6390 wild-type, sarZ mutant, and complemented sarZ mutant strains (left panel) and sarZ mutant, RN6390, sarZ mutant
expressing RNAIII in trans, and sarZ sarA double mutant (center panel). RNA was harvested from late exponential phase (spa) or
postexponential phase (hla, sspA) S. aureus cells. The lightness of the spa band in the middle portion of panel A was due to underexposure
of the film, which allowed us to visualize the intensity of the spa band in the sarZ sarA double mutant. Numbers underneath the panels
indicate the relative intensities of the bands as determined with ImageJ. Right panels. GFP-fusion analyses of the spa (A), hla (B), and sspA
(C) promoter activities in RN6390, sarZ mutant, and complemented strains of S. aureus. *, P  0.01 determined by Student’s t test. D.
Protease activity of the wild-type RN6390, sarZ mutant, and complemented sarZ mutant strains of S. aureus. Top: proteolysis on skimmed
milk agar. Bottom: proteolysis on a gelatin-containing polyacrylamide gel.
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on this strain, we found that a mutation in sarZ decreased agr
transcription. Consistent with an agr-deficient phenotype, the
transcription of spa was increased in the sarZ mutant, while
the transcription of hla was decreased. Given that SarA upregu-
lates hla and downmodulates spa, it is likely that the effects of
SarZ on protein A and alpha-hemolysin gene expression are
mediated primarily via agr rather than SarA (27). The drastic
reduction of sspA transcription was first thought to be due to
the augmented SarA expression and/or decreased agr RNAIII
levels in the sarZ mutant. However, subsequent results with a
sarA sarZ double mutant and a sarZ mutant overexpressing
RNAIII demonstrated that the effect of sarZ upon sspA likely
occurred independently of these two global regulators. Previ-
ous work by Kaito et al. (18) demonstrated the direct binding
of SarZ to the hla and agr promoter, thus providing evidence
that SarZ may directly regulate these genes. Whether this
DNA binding activity also applies to the sarA, sspA, or spa
promoters will require further study, especially in light of the
finding that the binding of SarZ to DNA may be nonspecific
(18).
Our observation that sarZ represses sarA (an activator of
agr) and upregulates agr suggested that the activation of agr by
SarZ occurred independently of SarA. We initially hypothe-
sized that SarZ may act via SarR, a repressor of SarA and
activator of agr (22). However, analysis of sarR transcription in
a sarZ mutant did not reveal any reproducible changes with
respect to the wild-type strain, suggesting that SarZ likely reg-
ulates agr and sarA independently of SarR. Based on the ob-
served decrease in mgrA transcription in the sarZ mutant and
its role in agr activation (16), MgrA was next examined as a
potential intermediary between SarZ and agr. Provision of
MgrA under the control of an exogenous promoter to the sarZ
mutant repressed biofilm formation but was not sufficient in
restoring the transcription of agr and its downstream target
genes, sspA and hla (Fig. 6; hla data not shown), suggesting
that SarZ or another factor controlled by SarZ was required
for optimal agr activation. Detailed analysis of the binding
activity of SarZ to the RNAIII promoter, alone or in conjunc-
tion with other regulators, such as SarA and MgrA, is required
to fully appreciate the mechanistic details of agr regulation by
SarZ.
The effect of sarZ on sarA expression is quite complex due to
the intricacy of the triple promoters that drive the expression
of sarA (5). Northern blot analysis revealed that sarZ may
repress sarA due to its effect on the proximal P1 promoter
during late exponential phase, which coincides with maximal
sarZ transcription. GFP-promoter fusion analysis, however,
suggested that the effect of SarZ upon sarA transcription may
be attributable to the cumulative actions of SarZ on all three
promoters throughout the growth cycle rather than on the sarA
P1 promoter alone. Whether the discrepancy between sarA
promoter activity and SarA protein expression levels in the
FIG. 4. A sarZ mutant hyperproduces biofilms rich in proteins. A.
Quantitation of biofilm formation on 96-well polystyrene plates. *, P 
0.01 compared to the wild-type strain RN6390 determined by Student’s
t test. B. Detachment of biofilms formed by RN6390 and the sarZ
mutant after treatment with proteinase K or DNase I for 2 h. *, P 
0.01 compared to the buffer control; **, P  0.05 compared to the
buffer control. Panels beneath the graphs show representative wells
with the crystal violet staining phenotype of the biofilms.
FIG. 5. Protease-mediated detachment of biofilms produced by a
sarZ mutant. Top, biofilm formation of RN6390, the sarZ mutant, and
the sarZ mutants containing either pEPSA5 (VC) or pEPSA5::sspA
(SspA). Cells were grown on 66% TSB, 2% glucose, and 2% xylose to
induce both biofilm formation and SspA production. *, P  0.01
compared to the parental strain RN6390 as determined with Student’s
t test; **, P  0.05 compared to the RN6390 parental strain. Middle
panels, protease activity of the indicated strains on a gelatin-containing
polyacrylamide gel. Bottom panels, representative wells showing the
crystal violet staining phenotype of the biofilms.
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sarZ mutant is attributable to an additional level of posttran-
scriptional control or occurs in conjunction with another reg-
ulator(s) remains to be defined. Indeed, both SarA and SarR
can bind to and repress the sarA P1 promoter, thus indicating
the complexity through which SarA protein expression may be
controlled in S. aureus (6, 20).
As the sarZ mutant exhibited elevated SarA protein expres-
sion, we speculated that the sarZ mutant may have an en-
hanced biofilm phenotype. Previously, SarA has been shown to
be essential to biofilm formation by activating the ica genes,
which are required to synthesize PNAG, a major biofilm matrix
component, and bap, encoding a protein adhesin found only in
bovine isolates of S. aureus (33). However, the transcription of
the ica genes was not altered in the sarZ mutant compared with
FIG. 6. Effect of sarZ on mgrA. A. Left panel. Northern blot analysis of mgrA transcription in RN6390, sarZ mutant, and complemented sarZ
mutant strains of S. aureus during late exponential phase. Numbers underneath the panels indicate the relative intensities of the bands as
determined with ImageJ. Right panel. GFP-fusion analysis of the mgrA promoter activity in RN6390, sarZ mutant, and complemented strains of
S. aureus. *, P  0.01 as determined by Student’s t test. B. Top, biofilm formation of RN6390, the sarZ mutant, and the sarZ mutants containing
pEPSA5 (VC) or pEPSA5::mgrA (MgrA). Cells were grown on 66% TSB, 2% glucose, and 2% xylose to induce both biofilm formation and MgrA
production. *, P  0.01 compared to RN6390; **, P  0.05 compared to RN6390. Bottom panels, representative wells showing the crystal violet
staining phenotype of the biofilms. C. Top two panels, transcription of agr and sspA in RN6390, sarZ mutant, and complemented sarZ mutant
strains of S. aureus as determined by Northern blotting. Numbers beside the panels indicate the relative intensities of the bands as determined with
ImageJ. Bottom panels, protease activity of the indicated strains on a gelatin-containing polyacrylamide gel.
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the parental strain. Detachment studies with proteinase K and
DNase I indicated that the major constituents of biofilms of
sarZ mutants are likely proteins rather than a carbohydrate
such as PNAG. Accordingly, there appear to be two plausible
scenarios by which SarZ may repress biofilm formation in S.
aureus: (i) by repressing surface adhesin expression via down-
regulation of SarA and (ii) through the activation of an inhib-
itory or detachment factor such as a protease. One likely can-
didate for a detachment factor was the V8 protease, SspA,
since it was strongly repressed in the sarZ mutant. Provision of
sspA in trans to the mutant restored the biofilm phenotype to
the parental level. However, a recent publication as well as
unpublished data from our lab have demonstrated that an sspA
mutant alone does not result in an enhanced biofilm pheno-
type, contrary to what one would expect if SspA were a major
detachment factor (2). Therefore, we conclude that while sspA
is not essential for biofilm formation, high levels of the pro-
tease can contribute to biofilm detachment by acting as a
general protease, much like proteinase K.
MgrA has also been described as a negative regulator of
biofilm formation that acts in an ica-independent manner (34).
Given the similarities between the biofilms of sarZ and mgrA
mutants, we sought to determine whether SarZ controlled
mgrA with respect to biofilm formation. Indeed, mgrA tran-
scription was decreased in the sarZ mutant in comparison to
the wild-type strain. Importantly, the enhanced biofilm pheno-
type of the sarZ mutant returned to near parental levels when
mgrA was provided in trans via a plasmid with a xylose-induc-
ible promoter. We also monitored agr and sspA transcription in
this sarZ mutant derivative and determined that this MgrA-
overproducing construct did not restore the transcription of
these genes to the levels of the parental strain, RN6390. The
lack of protease activity in this sarZ mutant derivative implied
that increased expression of a surface adhesin(s), possibly via
the downregulation of mgrA and/or agr, may account for the
enhanced biofilm phenotype in the absence of SarZ. Whether
the upregulation of SarA in the sarZ mutant contributes to
further enhancement of biofilm formation via the expression of
additional surface protein adhesin(s) remains to be deter-
mined.
Taken together, our results demonstrate that SarZ upregu-
lates agr and represses SarA expression to promote the expres-
sion of virulence genes, such as hla and sspA. Additionally, the
sarZ locus also controls mgrA and agr to repress biofilm for-
mation. Repression of biofilm formation prevents the estab-
lishment of sessile bacterial communities and hence promotes
active infections. In addition, concomitant expression of toxic
FIG. 7. Effects of sarZ are conserved in SH1000. A. Transcription
of sarZ during the early exponential (OD650, 0.7), late exponential
(OD650, 1.1), and postexponential (OD650, 1.7) phases of growth. B.
Effects of sarZ upon SarA, agr, and mgrA expression during late ex-
ponential (SarA, mgrA) and postexponential (agr) growth. Top panel,
protein levels of SarA in the SH1000 wild-type strain and two inde-
pendently isolated sarZ mutant clones of S. aureus as determined by
Western blot analysis. Middle and bottom panels, Northern blot anal-
ysis of the transcription of agr RNAIII (middle) and mgrA (bottom) in
the wild-type SH1000 strain and two independently isolated sarZ mu-
tant clones of S. aureus. Numbers beneath the panels indicate the
relative intensities of the bands as determined with ImageJ. C. Biofilm
formation of SH1000 and an isogenic sarZ mutant in a 96-well poly-
styrene plate. , P  0.05 as determined by Student’s t test.
FIG. 8. Proposed mechanism of virulence gene regulation by SarZ.
SarZ represses sarA and activates mgrA, leading to the downregulation
of genes important to biofilm formation. Activation of agr by SarZ also
leads to the upregulation of hla (alpha-hemolysin) and repression of
spa (protein A). Additionally, SarZ activates the production of the
SspA protease independently of both agr and sarA. These changes in
gene expression result in a net decrease in surface adhesins and in-
crease in toxins, which likely enable the bacteria to spread to new sites
of infection.
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proteins, such as alpha-hemolysin and V8 protease in a sarZ-
positive strain, would lead to tissue damage and promote the
spread of bacteria to new infection sites. Accordingly, we pro-
pose that SarZ is an important regulator required for the
maintenance and spread of active S. aureus infections.
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